Last reviewed · How we verify
Neuralgia
Approved treatments
- Qutenza · Averitas
- Lignocaine · University of Malaya
- Lignospan Forte · Fresenius Kabi
Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction. - Lidocain · Bayer
- xylocain · Saint-Joseph University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Neuralgia patent landscape — cliff calendar, originator estates, attackable patents
- Neuralgia treatment landscape brief
- Neuralgia treatment updates RSS
Frequently asked questions about Neuralgia
What drugs treat Neuralgia?
Tracked treatments include Qutenza, Lignocaine, Lignospan Forte, Lidocain, xylocain.
What is the treatment for Neuralgia?
Standard treatment for Neuralgia includes Qutenza, Lignocaine, Lignospan Forte, Lidocain, xylocain. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Neuralgia patent cliff · Neuralgia CI report
- Treatment: Qutenza · Averitas
- Treatment: Lignocaine · University of Malaya
- Treatment: Lignospan Forte · Fresenius Kabi
- Treatment: Lidocain · Bayer
- Treatment: xylocain · Saint-Joseph University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing